OPTN/SRTR 2021 Annual Data Report: Lung

The number of lung transplants has continued to decline since 2020, a period that coincides with the onset of the COVID-19 pandemic. Lung allocation policy continues to undergo considerable change in preparation for adoption of the Composite Allocation Score system in 2023, beginning with multiple a...

Descripción completa

Detalles Bibliográficos
Autores principales: Valapour, Maryam, Lehr, Carli J., Schladt, David P., Smith, Jodi M., Goff, Rebecca, Mupfudze, Tatenda G., Swanner, Kaitlin, Gauntt, Katrina, Snyder, Jon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970343/
https://www.ncbi.nlm.nih.gov/pubmed/37132345
http://dx.doi.org/10.1016/j.ajt.2023.02.009
Descripción
Sumario:The number of lung transplants has continued to decline since 2020, a period that coincides with the onset of the COVID-19 pandemic. Lung allocation policy continues to undergo considerable change in preparation for adoption of the Composite Allocation Score system in 2023, beginning with multiple adaptations to the calculation of the Lung Allocation Score that occurred in 2021. The number of candidates added to the waiting list increased after a decline in 2020, while waitlist mortality has increased slightly with a decreased number of transplants. Time to transplant continues to improve, with 38.0% of candidates waiting fewer than 90 days for a transplant. Posttransplant survival remains stable, with 85.3% of transplant recipients surviving to 1 year; 67%, to 3 years; and 54.3%, to 5 years.

Ejemplares similares